Clinical Trial Update: A Single Arm Pilot Study of Azacitidine in Myelodysplastic Syndromes (MDS) / Acute Myeloid Leukaemia (AML), With Eltrombopag Support for Thrombocytopenia [Phase 2]

View source ↗

Summary

Phase 2 single-arm pilot trial evaluating azacitidine in myelodysplastic syndromes and acute myeloid leukemia with eltrombopag support for thrombocytopenia has …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndromes

Drugs mentioned

• AZACITIDINE (AZACITIDINE)
• Eltrombopag (eltrombopag)

Snippet

Sponsor: Peter MacCallum Cancer Centre, Australia | Conditions: Myelodysplastic Syndromes (MDS), Acute Myeloid Leukaemia (AML) | Phase 2 | Status: COMPLETED